Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Issue Date
2020-01-19
Metadata
Show full item recordAbstract
No abstract availableCitation
Biomed Res Int. 2020 Jan 19;2020:6532827. doi: 10.1155/2020/6532827Affiliation
HIPS, Helmholtz-Institut für Pharmazeutische Forschung Saarland, Universitätscampus E8.1 66123 Saarbrücken, Germany.Publisher
HindawiJournal
BioMed research internationalPubMed ID
32695817Type
EditorialLanguage
enEISSN
2314-6141ae974a485f413a2113503eed53cd6c53
10.1155/2020/6532827
Scopus Count
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 4.0 International
Related articles
- Multitarget-directed ligands for neurodegenerative diseases: real opportunity or blurry mirage?
- Authors: Benchekroun M, Maramai S
- Issue date: 2019 Feb
- Pharmacological Approaches Targeting Brain Cell Survival in the Context of Neurodegeneration and Potential Treatment Strategies.
- Authors: Aliev G
- Issue date: 2019
- PPARs: a new target for neuroprotection.
- Authors: Bordet R, Gelé P, Duriez P, Fruchart JC
- Issue date: 2006 Mar
- Melatonin as a versatile molecule to design novel multitarget hybrids against neurodegeneration.
- Authors: Ramos E, Egea J, de Los Ríos C, Marco-Contelles J, Romero A
- Issue date: 2017 May
- Pediatric use of tetracyclines: focus on neurodevelopmental effects.
- Authors: Inta I, Hoffmann GF, Bettendorf M
- Issue date: 2017 Nov